Showing 114 of 114on this page. Filters & sort apply to loaded results; URL updates for sharing.114 of 114 on this page
MaxCyte VLX Large Scale Transfection System - Spincotech
Scale-up Ion Channel Expression using MaxCyte Transfection
Transfection Reagents and Supporting Products | MaxCyte
MaxCyte Highlights Innovations in High-throughput Transfection for Cell ...
Overcome the limitations of conventional transfection with MaxCyte ...
Overcome Limitations of Transfection with MaxCyte Electroporation
MaxCyte STX Scalable Transfection System
MaxCyte STX Scalable Transfection System | eBay
Overcome the Limitations of Conventional Transfection with MaxCyte ...
Stem Cell Transfection | MaxCyte
MaxCyte STX Scalable Transfection System | AllSurplus
MaxCyte ATX Transfection System | eBay
ExPERT ATx™ Electroporator | MaxCyte
Our Electroporation Technology | MaxCyte
MaxCyte ExPERT GTx Scalable Electroporation System - Spincotech
Protein & Antibody Production | MaxCyte
Resource Library | MaxCyte
MaxCyte Workflow for Mammalian Display | MaxCyte
MaxCyte Electroporation Optimizes Transposon Delivery in CAR T Cells
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio
Here’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as ...
MaxCyte Q1 Earnings Call Highlights
MaxCyte, Inc: MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
MaxCyte outlines $30M-$32M 2026 revenue outlook as board authorizes ...
MaxCyte (MXCT) Reports Strong Q1 2026 — Revenue $N/A, EPS Beats ...
MaxCyte overtreft Q1 2026-verwachtingen met sterke inkomsten Door ...
Improving Electroporation Efficiency of T Cells | MaxCyte
Ignite Your Cell Therapy Development | MaxCyte
Accelerate Antibody Development and Production | MaxCyte
Bioprocess Development & Protein Production | MaxCyte
MaxCyte Workflow for Mammalian Display | MaxCyte | MaxCyte, Inc.
Vaccine Development | MaxCyte
Electroporation Process | MaxCyte
MaxCyte | Best-in-Class Electroporation Systems | MaxCyte, Inc.
Electroporation Buffers | MaxCyte
Collaborate With MaxCyte | MaxCyte
Lower Clinical Risk Cell Therapy with Early GMP Compliance | MaxCyte
Cell Engineering Workflows with MaxCyte Scalable Electroporation
Electroporators | MaxCyte
What Cells Can I Use | MaxCyte
MaxCyte® Enables Multiplexed NK Cell Engineering | MaxCyte
MaxCyte, Inc. on LinkedIn: Collaborate With MaxCyte | MaxCyte
CRISPR Electroporation | MaxCyte
Enabling Scalable Cell Engineering Using the Electroporation | MaxCyte
MaxCyte Helps Engineer Difficult-to-Transfect Immune Cells
Viral Vector Development | MaxCyte
#celltherapy #geneediting #electroporation #dggt2025 #maxcyte | MaxCyte ...
Large-Scale Virus-Like Particle Manufacturing for Gene Editing | MaxCyte
MaxCyte ExPERT™ platforms (DTx, ATx, STx, GTx, VLx) - TrendBio
The ExPERT GTx electroporation technology | MaxCyte
Gene Editing | MaxCyte
Cell Transfection - Spincotech
MaxCyte (MXCT): Cell Engineering and Biotechnology Solutions
Protein Engineering Stanford at Gerald Anderson blog
Trinity Delta Enabling cell therapies to progress - Trinity Delta
Engineering Difficult-to-Transfect Immune Cells Using Electroporation ...
MaxCyte® Scalable Electroporation: A Universal Cell Engineering ...
MaxCyte, Inc. Q1 2026 Earnings Call Summary
MXCT Q2 2025 Earnings Report on 8/6/2025
MAXCYTE-Aktie über 100-Tage-Linie - boerse.de
MaxCyte® Flow Electroporation® for Gram-Scale Transient Antibody ...
Nucleocounter SP 100 Sperm Cell Counter - Spincotech
MaxCyte, Inc.
[자연과학(주)/MaxCyte] 항체 생산, 세포주 개발 및 재조합 단백질 생산을 위한 MaxCyte® Flow ...
CONCEPT | Cell Therapy - CONCEPT
신제품신기술 > Bio마켓 > BRIC
Achieving Therapeutic Efficacy - High-Performance Electroporation
冷泉港生物科技股份有限公司
High Efficiency Complex Gene Editing of Hard-to-Transfect Primary Cells ...
Featured Holdings – CONSTANCE
